Skip to content

Qiagen NV

US · QGEN #1551 by market cap Listed 1970
49.30 -0.33 -0.66%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 49.55 -0.16%
After-hours 49.30 0.00%
50.8635.2249.302026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on QGEN?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Neutral
  • Recent price momentum is +9.4% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days C → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 14:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall C+
ValuationGrowthProfitMomentumHealthAnalyst
Valuation C-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 27.1x Better than 27%
Forward P/E 21.2x Better than 33%
Price / Sales 4.9x Better than 23%
P/E vs own 5-yr range 51st pctl Better than 58%
Growth C-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) -0.8% Better than 21%
Net income CAGR (3Y) 0.1% Better than 41%
Free cash flow CAGR (3Y) -7.5% Better than 30%
Profitability A-

How much profit the business keeps from each dollar of sales and capital.

Gross margin 62.2% Better than 76%
Operating margin 24.9% Better than 84%
Net margin 20.3% Better than 80%
Return on equity 11.6% Better than 57%
Return on invested capital 7.5% Better than 58%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 11.9% Better than 92%
6-month return 41.4% Better than 93%
12-month return (ex latest month) 8.5% Better than 45%
Distance below 52-week high 14.0% Better than 74%
Financial Health B+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.9x Better than 80%
Debt to assets 28.9% Better than 43%
Interest coverage 15.7x Better than 79%
Free cash flow / net income 105.3% Better than 42%
Analyst View D

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 40.0% Better than 21%
Upside to average target 3.3% Better than 6%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -1.18%
1M +0.82%
3M +9.80%
6M +41.76%
YTD +10.62%
1Y +8.92%
3Y +25.33%
5Y -9.93%

Key statistics

Price & volume

Prev close
49.63
Open
49.51
Day range
49.27 - 49.61
Avg price
49.44
Volume
2.63M
Turnover
130.27M
Amplitude
0.69%
52-week range
32.24 - 57.30

Valuation

P/E
25.41
P/E (TTM)
27.09
P/B
2.93
EPS
1.94
Net profit
400.60M
Net assets
3.47B

Share structure

Market cap
10.18B
Float cap
10.11B
Shares out
206.50M
Float shares
205.17M

Dividend & listing

Dividend (TTM)
0.35
Listing date
1970-01-01
52-week range 68% of range
32.24 57.30

14.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-368.42M net over the window

Short interest

Shares short
6.40M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Qiagen NV (QGEN)?

Qiagen NV last traded at 49.30. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Qiagen NV's market cap?

About 10.18B.

What is the P/E ratio of Qiagen NV?

The trailing twelve-month P/E is 27.09, below its own 5-year average of 43.66 — in the middle of its historical range (51.44% percentile). See the Valuation tab for the full history.

Does Qiagen NV pay a dividend?

Yes. The trailing dividend yield is 0.71%. The 2025 payout was up 18.0% from 2024. See the Dividends tab for the full payment history.

Is Qiagen NV a buy according to analysts?

The consensus of 10 analysts is a Buy rating, with an average 12-month price target of 50.94, which implies 3.3% upside from the current price. This is not investment advice.

What is Qiagen NV's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Qiagen NV a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Qiagen NV discussion 0 comments

Add a comment